Question · asked by 1 review

Methotrexate vs 6‐MP or azathioprine: Withdrawals due to adverse events

It is very uncertain whether methotrexate changes withdrawal due to adverse event (Oren 1997) compared with 6‐MP or azathioprine (very low certainty).

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Methotrexate vs 6‐MP or azathioprine
Withdrawal due to adverse event (Oren 1997) · adult patients with refractory Crohn's disease
It is very uncertain whether methotrexate changes withdrawal due to adverse event (Oren 1997) compared with 6‐MP or azathioprine (very low certainty).
Methotrexate for induction of remission in refractory Crohn's disease (2014) · Cochrane Headline outcomes only
RR 1.23 [0.08, 18.74]1 study · 58 participantsVery low
Methotrexate vs 6‐MP or azathioprine
Withdrawal due to adverse event (Maté‐Jiménez 2000) · adult patients with refractory Crohn's disease
It is very uncertain whether methotrexate changes withdrawal due to adverse event (Maté‐Jiménez 2000) compared with 6‐MP or azathioprine (very low certainty).
Methotrexate for induction of remission in refractory Crohn's disease (2014) · Cochrane Headline outcomes only
RR 2.13 [0.22, 21.17]1 study · 31 participantsVery low
Methotrexate vs 6‐MP or azathioprine
Withdrawal due to adverse event (Ardizzone 2003) · adult patients with refractory Crohn's disease
It is very uncertain whether methotrexate changes withdrawal due to adverse event (Ardizzone 2003) compared with 6‐MP or azathioprine (very low certainty).
Methotrexate for induction of remission in refractory Crohn's disease (2014) · Cochrane Headline outcomes only
RR 1 [0.22, 4.52]1 study · 54 participantsVery low

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Methotrexate for induction of remission in refractory Crohn's disease
2014 · Cochrane Headline outcomes only
Not reportedlist not extracted yetNot assessed

Studies behind the findings

None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.